Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers Health, Inc. $HIMS Shares Sold by Dimensional Fund Advisors LP
04:16am, Thursday, 12'th Mar 2026
Dimensional Fund Advisors LP lessened its holdings in shares of Hims and Hers Health, Inc. (NYSE: HIMS) by 2.5% in the third quarter, according to the company in its most recent filing with the Securi
Hims & Hers: The Novo Nordisk Deal Changes Everything
12:15pm, Wednesday, 11'th Mar 2026
The Novo Nordisk partnership legitimizes Hims & Hers' business model by replacing compounded GLP-1 sales with branded Wegovy and Ozempic distribution. Hims generated $2.35B revenue in 2025 (+59% YoY)
Hims & Hers Brings In Lilly Communications Veteran
11:38am, Wednesday, 11'th Mar 2026
Hims and Hers Health (HIMS) is strengthening its communications leadership, bringing in Kathryn Beiser, the former chief communications officer at Eli Lilly (LLY)
This Novo Nordisk Partnership Shows That HIMS Has All The Leverage
10:40am, Wednesday, 11'th Mar 2026
Hims & Hers (HIMS) is still a Strong Buy, given that the transformative partnership with Novo Nordisk resolves legal risks and unlocks new growth avenues. HIMS' core value lies in its 2.5M+ cash-pay c
Two healthcare names are drawing fresh analyst attention this week as Wall Street recalibrates around a landmark GLP-1 truce and a fertility benefits company navigating a murky 2026 outlook.
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
08:08pm, Tuesday, 10'th Mar 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Office
Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track
04:43pm, Tuesday, 10'th Mar 2026
Hims & Hers Health, Inc. surges after securing a partnership with Novo Nordisk, resolving legal and regulatory overhangs tied to compounded GLP-1s. HIMS's long-term platform thesis centers on becoming
Asset Manager Exits Shares of Hims & Hers Health
04:07pm, Tuesday, 10'th Mar 2026
Hims and Hers Health has struggled, but it just inked a new partnership with Novo Nordisk.
What's Driving Attention Behind These Trending Stocks? MRVL, STRL, HIMS
04:05pm, Tuesday, 10'th Mar 2026
There have been several stocks gaining investors' interest recently, including Hims and Hers Health HIMS, Sterling Infrastructure STRL, and Marvell Technology MRVL.
Hims and Hers Expands Consumer-Focused Digital Health Platform
02:35pm, Tuesday, 10'th Mar 2026
HIMS expands its digital care platform with new specialties, lab testing and global moves as it scales personalized telehealth services.
Patience Pays: Hims & Hers Surges on News of Novo Nordisk Deal
02:03pm, Tuesday, 10'th Mar 2026
After falling 59% from its year-to-date (YTD) high, embattled healthcare stock Hims & Hers Health NYSE: HIMS is making headlines as shares are surging in the wake of an agreement with GLP-1 maker Novo
Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles
10:09am, Tuesday, 10'th Mar 2026
Three health-technology names are drawing fresh analyst attention this week as strategic partnerships and business pivots reframe the risk-reward calculus for each.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 10'th Mar 2026
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
09:00am, Tuesday, 10'th Mar 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best inno
Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil futures, which shot up to $120 overnight, retreated below $100 on Mond
